banner
Inquiry

Neutral Glycosylglycerols

Cat. No. Product Name Inquiry
X26-02-ZQ247 1-hexadecanyl-2-((2'-α-glucosyl)-β-glucosyl)-3-β-xylosyl-sn-glycerol
X26-02-ZQ248 SQMG(16:1(9Z)/0:0)
X26-02-ZQ249 SQMG(16:1(11Z)/0:0)
X26-02-ZQ250 SQMG(16:1(13Z)/0:0)
X26-02-ZQ251 SQMG(0:0/16:1(9Z))
X26-02-ZQ252 SQMG(0:0/16:1(11Z))
X26-02-ZQ253 SQMG(0:0/16:1(13Z))
X26-02-ZQ254 MGMG(16:2(7Z,10Z)/0:0)
X26-02-ZQ255 MGMG(16:3(7Z,10Z,13Z)/0:0)
X26-02-ZQ256 MGMG(18:2(9Z,12Z)/0:0)
X26-02-ZQ257 MGMG(18:5(3Z,6Z,9Z,12Z,15Z)/0:0)
X26-02-ZQ258 MGMG(18:4(6Z,9Z,12Z,15Z)/0:0)
X26-02-ZQ259 DGMG(18:4(6Z,9Z,12Z,15Z)/0:0)
X26-02-ZQ260 DGMG(18:5(3Z,6Z,9Z,12Z,15Z)/0:0)
X26-02-ZQ261 SQMG(18:0/0:0)
X26-02-ZQ262 MGMG(18:4;O/0:0)
X26-02-ZQ263 DGMG(16:0/0:0)
X26-02-ZQ264 Gingerglycolipid C
X26-02-ZQ265 Gingerglycolipid A
X26-02-ZQ266 SQMG(16:0/0:0)
X26-02-ZQ267 MGMG(18:3(9Z,12Z,15Z)/0:0)
X26-02-ZQ268 Gingerglycolipid B
X26-02-ZQ269 1-acyl-3-O-β-D-galactosyl-sn-glycerol
X26-02-ZQ270 SQGE(16:0/0:0)
X26-02-ZQ271 DGMG(16:1(3E)3Me,7ME,11Me,15Me)/0:0)
X26-02-ZQ272 MGDG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
X26-02-ZQ273 1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-3-O-α-D-glucuronyl-sn-glycerol
X26-02-ZQ274 1,2-dioctadecanoyl-3-O-(6-deoxy-6-amino-α-D-glucosyl)-sn-glycerol
X26-02-ZQ275 SQDG(16:0/16:0)
X26-02-ZQ276 SQDG(16:0/14:0)
X26-02-ZQ277 SQDG(16:0/16:1(9Z))
X26-02-ZQ278 SQDG(16:0/16:1(11Z))
X26-02-ZQ279 SQDG(16:0/16:1(13Z))
X26-02-ZQ280 SQDG(22:5(5Z,8Z,11Z,14Z,17Z)/16:1(13Z))
X26-02-ZQ281 DGDG(18:5(3Z,6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
X26-02-ZQ282 MGDG(18:5(3Z,6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
X26-02-ZQ283 MGDG(18:5(3Z,6Z,9Z,12Z,15Z)/18:5(3Z,6Z,9Z,12Z,15Z))
X26-02-ZQ284 MGDG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
X26-02-ZQ285 MGDG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
X26-02-ZQ286 DGDG(18:2(9Z,12Z)/18:2(9Z,12Z)[15(R)OH-18:2(9Z,12Z])

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0